ArticleAllergologie select2019
ARIA guideline 2019: treatment of allergic rhinitis in the German health system.
Article in Allergologie select, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 71 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
71 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- The incidence of sleepiness in newer-generation antihistamine users: a systematic review and network meta-analysis.European journal of clinical pharmacology · 2026Pooled it
- Low-Level Laser Therapy for Allergic Rhinitis: A Systematic Review and Meta-Analysis.International archives of allergy and immunology · 2024Pooled it
- Molecular Aspects of Allergen-Specific Immunotherapy in Patients with Seasonal Allergic Rhinitis.Cells · 2023Pooled it
- Comparison of Allergic Rhinitis Treatments on Utilities and Quality of Life: A MASK-air Study.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2026Observational
- Impact of Allergen-Specific Subcutaneous Immunotherapy on 12-Month Health-Related Quality of Life in Children and Their Parental Caregivers.Allergy, asthma & immunology research · 2026Article
- Between Guidelines and Daily Practice: The Persistent Use of Parenteral Depot Corticosteroids in Germany.Clinical and translational allergy · 2026Article
- Cytokines and immunologic checkpoint molecules in predicting success of allergen immunotherapy.Scientific reports · 2026Article
- Night-to-night variability in respiratory outcomes from home sleep testing in children with suspected sleep-disordered breathing: a retrospective analysis using real-world data.Sleep & breathing = Schlaf & Atmung · 2026Article
- Evaluating montelukast-second-generation antihistamine combinations versus monotherapy in allergic rhinitis: A network meta-analysis.Asia Pacific allergy · 2026Article
- Feasibility and efficacy of nasal rehabilitation on nasal symptoms in patients with chronic allergic rhinitis: A pilot study.The journal of allergy and clinical immunology. Global · 2026Article
- Article
- Refining the diagnosis of house dust mite-induced allergic rhinitis: optimizing SPT and sIgE cutoff values as predictors of clinically relevant allergy.Scientific reports · 2026Article
- Patient preferences in the treatment of children with pollen-related allergic rhinitis.Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology · 2026Article
- Assessment of the Effectiveness of Allergic Rhinitis Medications Using a Target Trial Emulation Approach Based on Mobile Health Data.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2026Article
- Administration Technique of Intranasal Corticosteroid Sprays Among Nepali Pharmacists: Cross-Sectional Study.JMIRx med · 2026Article
- The forgotten billion: bridging the global allergy care chasm through scalable, equity-driven strategies.Frontiers in allergy · 2026Review
- Actual use of PROMs in asthma and rhinitis recommended by guidelines in clinical settings: PROMUSE respiratory study.Frontiers in allergy · 2026Article
- Mechanistic Insights Into House Dust Mites Immunotherapy-Induced Desensitization for Sustained Protection of Allergic Rhinitis in Mice.Advances in pharmacological and pharmaceutical sciences · 2026Article
- Cost-effectiveness of antihistaminics in adults' patients with allergic rhinitis.Cost effectiveness and resource allocation : C/E · 2025Article
- Diagnosis and management of allergic rhinitis: An Indian expert consensus by otorhinolaryngologists.Asia Pacific allergy · 2025Review
11 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
51 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe number of patients affected by allergies is increasing worldwide. The resulting allergic diseases are leading to significant costs for health care and social systems. Integrated care pathways are needed to enable comprehensive care within the national health systems. The ARIA (Allergic Rhinitis and its Impact on Asthma) initiative develops internationally applicable guidelines for allergic respiratory diseases.
methodsARIA serves to improve the care of patients with allergies and chronic respiratory diseases. In collaboration with other international initiatives, national associations and patient organizations in the field of allergies and respiratory diseases, real-life integrated care pathways have been developed for a digitally assisted, integrative, individualized treatment of allergic rhinitis (AR) with comorbid asthma. In the present work, these integrated care pathways have been adapted to the German situation and health system.
resultsThe present ICP (integrated care pathway) guideline covers key areas of the care of AR patients with and without asthma. It includes the views of patients and other healthcare providers. DISCUSSION: A comprehensive ICP guideline can reflect real-life care better than traditional guideline models.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.